The crystal structure of bromide-bound GtACR1 reveals a pre-activated state in the transmembrane anion tunnel

  1. Hai Li
  2. Chia-Ying Huang
  3. Elena G Govorunova
  4. Oleg A Sineshchekov
  5. Adrian Yi
  6. Kenneth J Rothschild
  7. Meitian Wang
  8. Lei Zheng  Is a corresponding author
  9. John L Spudich  Is a corresponding author
  1. University of Texas Health Science Center at Houston, McGovern Medical School, United States
  2. Swiss Light Source, Paul Scherrer Institute, Switzerland
  3. Boston University, United States

Abstract

The crystal structure of the light-gated anion channel GtACR1 reported in our previous Research Article (Li et al., 2019) revealed a continuous tunnel traversing the protein from extracellular to intracellular pores. We proposed the tunnel as the conductance channel closed by three constrictions: C1 in the extracellular half, mid-membrane C2 containing the photoactive site, and C3 on the cytoplasmic side. Reported here, the crystal structure of bromide-bound GtACR1 reveals structural changes that relax the C1 and C3 constrictions, including a novel salt-bridge switch mechanism involving C1 and the photoactive site. These findings indicate that substrate binding induces a transition from an inactivated state to a pre-activated state in the dark that facilitates channel opening by reducing free energy in the tunnel constrictions. The results provide direct evidence that the tunnel is the closed form of the channel of GtACR1 and shed light on the light-gated channel activation mechanism.

Data availability

Diffraction data have been deposited in PDB under the accession code 7L1E.

The following data sets were generated

Article and author information

Author details

  1. Hai Li

    Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3969-6709
  2. Chia-Ying Huang

    Macromolecular Crystallography, Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7676-0239
  3. Elena G Govorunova

    Center for Membrane Biology, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    Competing interests
    Elena G Govorunova, as an inventor and The University of Texas Health Science Center at Houston has been granted a patent titled: Compositions and Methods for Use of Anion Channel Rhodopsins Patent # 10,519,205 granted Dec 31, 2019 by the US Patent and Trademark Office..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0522-9683
  4. Oleg A Sineshchekov

    Center for Membrane Biology, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    Competing interests
    Oleg A Sineshchekov, as an inventor and The University of Texas Health Science Center at Houston has been granted a patent titled: Compositions and Methods for Use of Anion Channel Rhodopsins Patent # 10,519,205 granted Dec 31, 2019 by the US Patent and Trademark Office..
  5. Adrian Yi

    Boston University, Boston, United States
    Competing interests
    No competing interests declared.
  6. Kenneth J Rothschild

    Boston University, Boston, United States
    Competing interests
    No competing interests declared.
  7. Meitian Wang

    Macromolecular Crystallography, Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland
    Competing interests
    No competing interests declared.
  8. Lei Zheng

    Center for Membrane Biology, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    For correspondence
    Lei.Zheng@uth.tmc.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7789-5234
  9. John L Spudich

    Center for Membrane Biology, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, United States
    For correspondence
    John.L.Spudich@uth.tmc.edu
    Competing interests
    John L Spudich, as an inventor and The University of Texas Health Science Center at Houston has been granted a patent titled: Compositions and Methods for Use of Anion Channel Rhodopsins Patent # 10,519,205 granted Dec 31, 2019 by the US Patent and Trademark Office..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4167-8590

Funding

National Institute of General Medical Sciences (R01GM027750)

  • John L Spudich

National Institute of General Medical Sciences (R35GM140838)

  • John L Spudich

Robert A. Welch Foundation (Endowed Chair AU-0009)

  • John L Spudich

American Heart Association (18TPA34230046)

  • Lei Zheng

National Science Foundation (CBET-1264434)

  • Kenneth J Rothschild

European Union's Horizon 2020 (Marie-Skłodowska-Curie grant agreement No. 701647)

  • Chia-Ying Huang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Li et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,238
    views
  • 180
    downloads
  • 10
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hai Li
  2. Chia-Ying Huang
  3. Elena G Govorunova
  4. Oleg A Sineshchekov
  5. Adrian Yi
  6. Kenneth J Rothschild
  7. Meitian Wang
  8. Lei Zheng
  9. John L Spudich
(2021)
The crystal structure of bromide-bound GtACR1 reveals a pre-activated state in the transmembrane anion tunnel
eLife 10:e65903.
https://doi.org/10.7554/eLife.65903

Share this article

https://doi.org/10.7554/eLife.65903

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Yamato Niitani, Kohei Matsuzaki ... Michio Tomishige
    Research Article

    The two identical motor domains (heads) of dimeric kinesin-1 move in a hand-over-hand process along a microtubule, coordinating their ATPase cycles such that each ATP hydrolysis is tightly coupled to a step and enabling the motor to take many steps without dissociating. The neck linker, a structural element that connects the two heads, has been shown to be essential for head–head coordination; however, which kinetic step(s) in the chemomechanical cycle is ‘gated’ by the neck linker remains unresolved. Here, we employed pre-steady-state kinetics and single-molecule assays to investigate how the neck-linker conformation affects kinesin’s motility cycle. We show that the backward-pointing configuration of the neck linker in the front kinesin head confers higher affinity for microtubule, but does not change ATP binding and dissociation rates. In contrast, the forward-pointing configuration of the neck linker in the rear kinesin head decreases the ATP dissociation rate but has little effect on microtubule dissociation. In combination, these conformation-specific effects of the neck linker favor ATP hydrolysis and dissociation of the rear head prior to microtubule detachment of the front head, thereby providing a kinetic explanation for the coordinated walking mechanism of dimeric kinesin.

    1. Structural Biology and Molecular Biophysics
    Christopher T Schafer, Raymond F Pauszek III ... David P Millar
    Research Article

    The canonical chemokine receptor CXCR4 and atypical receptor ACKR3 both respond to CXCL12 but induce different effector responses to regulate cell migration. While CXCR4 couples to G proteins and directly promotes cell migration, ACKR3 is G-protein-independent and scavenges CXCL12 to regulate extracellular chemokine levels and maintain CXCR4 responsiveness, thereby indirectly influencing migration. The receptors also have distinct activation requirements. CXCR4 only responds to wild-type CXCL12 and is sensitive to mutation of the chemokine. By contrast, ACKR3 recruits GPCR kinases (GRKs) and β-arrestins and promiscuously responds to CXCL12, CXCL12 variants, other peptides and proteins, and is relatively insensitive to mutation. To investigate the role of conformational dynamics in the distinct pharmacological behaviors of CXCR4 and ACKR3, we employed single-molecule FRET to track discrete conformational states of the receptors in real-time. The data revealed that apo-CXCR4 preferentially populates a high-FRET inactive state, while apo-ACKR3 shows little conformational preference and high transition probabilities among multiple inactive, intermediate and active conformations, consistent with its propensity for activation. Multiple active-like ACKR3 conformations are populated in response to agonists, compared to the single CXCR4 active-state. This and the markedly different conformational landscapes of the receptors suggest that activation of ACKR3 may be achieved by a broader distribution of conformational states than CXCR4. Much of the conformational heterogeneity of ACKR3 is linked to a single residue that differs between ACKR3 and CXCR4. The dynamic properties of ACKR3 may underly its inability to form productive interactions with G proteins that would drive canonical GPCR signaling.